BNP Paribas Financial Markets Has $2.74 Million Stake in Transcat, Inc. (NASDAQ:TRNS)

BNP Paribas Financial Markets lifted its holdings in shares of Transcat, Inc. (NASDAQ:TRNS - Free Report) by 64.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 22,661 shares of the scientific and technical instruments company's stock after acquiring an additional 8,844 shares during the quarter. BNP Paribas Financial Markets owned 0.25% of Transcat worth $2,737,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Conestoga Capital Advisors LLC raised its position in shares of Transcat by 17.9% during the 3rd quarter. Conestoga Capital Advisors LLC now owns 907,191 shares of the scientific and technical instruments company's stock worth $109,561,000 after purchasing an additional 137,830 shares during the period. Royce & Associates LP raised its holdings in Transcat by 8.2% during the third quarter. Royce & Associates LP now owns 511,701 shares of the scientific and technical instruments company's stock worth $61,798,000 after purchasing an additional 38,774 shares in the last quarter. Champlain Investment Partners LLC increased its position in shares of Transcat by 22.1% during the 3rd quarter. Champlain Investment Partners LLC now owns 409,500 shares of the scientific and technical instruments company's stock valued at $49,455,000 after purchasing an additional 74,169 shares during the period. Hood River Capital Management LLC lifted its holdings in shares of Transcat by 21.6% in the second quarter. Hood River Capital Management LLC now owns 196,838 shares of the scientific and technical instruments company's stock valued at $23,558,000 after buying an additional 34,947 shares during the period. Finally, Wealth Enhancement Advisory Services LLC raised its position in Transcat by 28.8% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 79,303 shares of the scientific and technical instruments company's stock worth $9,577,000 after acquiring an additional 17,743 shares in the last quarter. 98.34% of the stock is currently owned by hedge funds and other institutional investors.

Transcat Stock Performance

Shares of TRNS stock traded down $1.28 during midday trading on Friday, hitting $102.06. 42,134 shares of the company were exchanged, compared to its average volume of 55,069. Transcat, Inc. has a 52 week low of $94.29 and a 52 week high of $147.12. The firm has a market capitalization of $938.95 million, a P/E ratio of 52.19 and a beta of 0.70. The firm's 50 day moving average price is $112.70 and its two-hundred day moving average price is $120.65.

Transcat (NASDAQ:TRNS - Get Free Report) last announced its quarterly earnings data on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.47 by ($0.12). Transcat had a net margin of 6.63% and a return on equity of 7.36%. The firm had revenue of $67.83 million during the quarter, compared to the consensus estimate of $70.30 million. During the same period last year, the business earned $0.41 earnings per share. The business's revenue was up 8.0% compared to the same quarter last year. Analysts expect that Transcat, Inc. will post 1.76 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts have weighed in on the stock. Oppenheimer reiterated an "outperform" rating and set a $130.00 price objective (down from $155.00) on shares of Transcat in a research report on Wednesday, October 30th. StockNews.com downgraded shares of Transcat from a "hold" rating to a "sell" rating in a research report on Tuesday, October 29th. Craig Hallum lowered their price target on Transcat from $138.00 to $113.00 and set a "buy" rating on the stock in a report on Wednesday, October 30th. Northland Securities cut their price objective on Transcat from $130.00 to $110.00 and set a "market perform" rating for the company in a research report on Wednesday, October 30th. Finally, HC Wainwright reissued a "buy" rating and issued a $156.00 price target on shares of Transcat in a report on Tuesday, October 29th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $127.25.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.